関連する実験動画

Updated: Aug 20, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

アフリカン・オンコサーキアシス患者におけるアイヴァルメクチンとディエチルカルバマジンのダブルブラインド試験で,眼球の関わりが認められた

M Lariviere, P Vingtain, M Aziz

    Lancet (London, England)
    |July 27, 1985
    PubMed
    まとめ

    単一の投与量であるイヴァルメクチンは,オンコサーキア症の治療において,ダイエチルカルバマジン (DEC) よりも有効であることが示されました. この研究では,イバメクチンがマイクロフィラリアを減少させ,より少ない副作用で眼の症状を和らげることに優れていることが判明しました.

    さらに関連する動画

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents10:10

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

    Published on: February 15, 2022

    Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats06:30

    Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

    Published on: May 23, 2025

    関連する概念動画

    Blind Procedures02:07

    Blind Procedures

    Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
    Blinding01:11

    Blinding

    Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
    Ophthalmic Drug Delivery Systems01:23

    Ophthalmic Drug Delivery Systems

    Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
    Anthelminthic Agents01:15

    Anthelminthic Agents

    Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...